These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30912024)

  • 1. Use of CRISPR/Cas9 for the Modification of the Mouse Genome.
    Klimke A; Güttler S; Kuballa P; Janzen S; Ortmann S; Flora A
    Methods Mol Biol; 2019; 1953():213-230. PubMed ID: 30912024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Editing of Mouse Embryonic and Epiblast Stem Cells.
    Sibbritt T; Osteil P; Fan X; Sun J; Salehin N; Knowles H; Shen J; Tam PPL
    Methods Mol Biol; 2019; 1940():77-95. PubMed ID: 30788819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application and optimization of CRISPR-Cas9-mediated genome engineering in axolotl (Ambystoma mexicanum).
    Fei JF; Lou WP; Knapp D; Murawala P; Gerber T; Taniguchi Y; Nowoshilow S; Khattak S; Tanaka EM
    Nat Protoc; 2018 Dec; 13(12):2908-2943. PubMed ID: 30429597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene editing in mouse zygotes using the CRISPR/Cas9 system.
    Wefers B; Bashir S; Rossius J; Wurst W; Kühn R
    Methods; 2017 May; 121-122():55-67. PubMed ID: 28263886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysing the outcome of CRISPR-aided genome editing in embryos: Screening, genotyping and quality control.
    Mianné J; Codner GF; Caulder A; Fell R; Hutchison M; King R; Stewart ME; Wells S; Teboul L
    Methods; 2017 May; 121-122():68-76. PubMed ID: 28363792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Efficient Knock-in Mouse and Human Pluripotent Stem Cells Using CRISPR-Cas9.
    Anzai T; Hara H; Chanthra N; Sadahiro T; Ieda M; Hanazono Y; Uosaki H
    Methods Mol Biol; 2021; 2320():247-259. PubMed ID: 34302663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Transgenic Mice Using CRISPR /Cas9 Technology.
    El Marjou F; Jouhanneau C; Krndija D
    Methods Mol Biol; 2021; 2214():125-141. PubMed ID: 32944907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-mediated genome editing in plants.
    Liu X; Xie C; Si H; Yang J
    Methods; 2017 May; 121-122():94-102. PubMed ID: 28315486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reporter does CRISPR.
    Cohen J
    Science; 2016 Nov; 354(6312):541. PubMed ID: 27811249
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimization of the production of knock-in alleles by CRISPR/Cas9 microinjection into the mouse zygote.
    Raveux A; Vandormael-Pournin S; Cohen-Tannoudji M
    Sci Rep; 2017 Feb; 7():42661. PubMed ID: 28209967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Mouse Model (KI and CKO) via Easi-CRISPR.
    Shola DTN; Yang C; Han C; Norinsky R; Peraza RD
    Methods Mol Biol; 2021; 2224():1-27. PubMed ID: 33606203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a Knockout Mouse Embryonic Stem Cell Line Using a Paired CRISPR/Cas9 Genome Engineering Tool.
    Wettstein R; Bodak M; Ciaudo C
    Methods Mol Biol; 2016; 1341():321-43. PubMed ID: 25762293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9 Genome Editing in Human Cell Lines with Donor Vector Made by Gibson Assembly.
    Sahoo N; Cuello V; Udawant S; Litif C; Mustard JA; Keniry M
    Methods Mol Biol; 2020; 2115():365-383. PubMed ID: 32006411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroporation of Cas9 protein/sgRNA into early pronuclear zygotes generates non-mosaic mutants in the mouse.
    Hashimoto M; Yamashita Y; Takemoto T
    Dev Biol; 2016 Oct; 418(1):1-9. PubMed ID: 27474397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
    Chen S; Lee B; Lee AY; Modzelewski AJ; He L
    J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.